AQST R&D Expenses
Aquestive Therapeutics Inc · R&D Expenses
AQST R&D Expenses
Latest reported$15.89Mperiod ending
AQST TTM R&D Expenses ($22.14M → $15.89M)
TTM R&D Expenses
High-resolution chart · PNG
AQST r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 15,892,000 | |
| 16,035,000 | |
| 17,192,000 | |
| 18,913,000 | |
| 19,652,000 | |
| 19,709,000 | |
| 20,280,000 | |
| 18,251,000 | |
| 16,178,000 | |
| 15,489,000 | |
| 13,104,000 | |
| 14,494,000 | |
| 14,530,000 | |
| 16,255,000 | |
| 17,481,000 | |
| 17,603,000 | |
| 19,097,000 | |
| 18,161,000 | |
| 17,047,000 | |
| 17,072,000 | |
| 19,606,000 | |
| 19,191,000 | |
| 19,886,000 | |
| 18,518,000 | |
| 16,321,000 | |
| 20,625,000 | |
| 20,574,000 | |
| 23,200,000 | |
| 22,671,000 | |
| 22,514,000 | |
| 23,112,000 | |
| 23,700,000 | |
| 24,850,000 | |
| 21,693,000 | |
| 22,135,000 |